Back

Difference in effect of statin on prognosis in heart failure with preserved and reduced ejection fraction

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Assistant Professor Se Yong Jang

Kyungpook National University Hospital, Daegu (Korea (Republic of))

43 More presentations in this session

Presentation thumbnail
REMODEL: Demonstration of REverse ReMODELing Effects of sacubitril/valsartan
Presentation thumbnail
Skeletal muscle metabolism characteristics of HFpEF and HFrEF patients
Doctor N. Jauert (Berlin, DE)
Abstract
Presentation thumbnail
Morphological structure of diaphragm in patients with different class of heart failure
Doctor K. Ilina (RU)
Abstract Slides
Presentation thumbnail
Clinical phenotypes and prognosis of patients with chronic heart failure with mid-range ejection fraction
Presentation thumbnail
Predictors of non-recovery of left ventricular systolic function in breast cancer patients with chemotherapy induced left ventricular dysfunction
Doctor H. Yoon (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources